David Tordrup
Impact in
- Hepatology top 10%
- Hepatitis C virus research
- Economics and Econometrics top 10%
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 8
- Pharmaceutical Economics and Policy 6
- Healthcare Policy and Management 3
-
- Viral gastroenteritis research and epidemiology 3
- Co-authors
- Panos Kanavos (5 shared papers)Aris Angelis (3 shared papers)Jean Mossman (1 shared paper)Félicie F. Andersen (5 shared papers)Birgitta R. Knudsen (4 shared papers)Aliya Naheed (1 shared paper)Zaheer‐Ud‐Din Babar (1 shared paper)Nick Scott (2 shared papers)
- Journals
- Health Policy (4 papers)Human Vaccines & Immunotherapeutics (2 papers)ACS Nano (2 papers)International Journal of Technology Assessment in Health Care (2 papers)The Lancet Global Health (1 paper)
- Partner nations
- United KingdomNetherlandsUnited States
In The Last Decade
David Tordrup
25 papers receiving 619 citations
Peers
Comparison fields: 5 of 98
- Hepatology 51
- Economics and Econometrics 114
- Family Practice 5
- Genetics 71
- Geriatrics and Gerontology 8
Countries citing papers authored by David Tordrup
This map shows the geographic impact of David Tordrup's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Tordrup with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Tordrup more than expected).
Fields of papers citing papers by David Tordrup
This network shows the impact of papers produced by David Tordrup. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Tordrup. The network helps show where David Tordrup may publish in the future.
Co-authors
The 25 scholars most cited alongside David Tordrup, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 204 | |
| 2 | 2019 | 59 | |
| 3 | 2014 | 52 | |
| 4 | 2019 | 47 | |
| 5 | 2010 | 45 | |
| 6 | 2009 | 25 | |
| 7 | Orphan drug considerations in Health Technology Assessment in eight European countries | 2014 | 24 |
| 8 | Global return on investment and cost-effectiveness of WHO's HEAR interventions for hearing loss : a modelling study | 2022 | 20 |
| 9 | 2016 | 18 | |
| 10 | 2022 | 17 | |
| 11 | 2016 | 16 | |
| 12 | 2020 | 15 | |
| 13 | 2011 | 11 | |
| 14 | 2013 | 11 | |
| 15 | 2022 | 11 | |
| 16 | 2020 | 9 | |
| 17 | 2016 | 8 | |
| 18 | 2011 | 8 | |
| 19 | Topoisomerase I deficiency results in chromosomal alterations in cervical cancer cells. | 2010 | 8 |
| 20 | 2017 | 6 |
About David Tordrup
David Tordrup is a scholar working on Economics and Econometrics, Infectious Diseases, Molecular Biology, Public Health, Environmental and Occupational Health and General Health Professions, having authored 27 papers that have together received 631 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (8 papers), Pharmaceutical Economics and Policy (6 papers), Viral gastroenteritis research and epidemiology (3 papers), Healthcare Policy and Management (3 papers), Pharmaceutical industry and healthcare (2 papers), RNA Interference and Gene Delivery (2 papers), Cancer therapeutics and mechanisms (2 papers) and DNA and Nucleic Acid Chemistry (2 papers). The work is most often cited by research in Hepatology (51 citations), Economics and Econometrics (114 citations), Family Practice (5 citations), Genetics (71 citations) and Geriatrics and Gerontology (8 citations). David Tordrup has collaborated with scholars based in United Kingdom, Netherlands and United States. Frequent co-authors include Panos Kanavos, Aris Angelis, Jean Mossman, Félicie F. Andersen, Birgitta R. Knudsen, Aliya Naheed, Zaheer‐Ud‐Din Babar, Nick Scott, Andrew Ball and Karin Stenberg. Their work appears in journals such as Health Policy, Human Vaccines & Immunotherapeutics, ACS Nano, International Journal of Technology Assessment in Health Care and The Lancet Global Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.